MyoGene Bio

Recent Finacing

Equity

Recent Raise

$0.4M

MyoGene Bio is a San Diego–based biotech developing a gene-editing therapy (MyoDys45-55) aimed at permanently restoring dystrophin production for Duchenne muscular dystrophy patients.

California, United States

1-10

Private

myogenebio.com